Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Liabilities: 2018-2019

Historic Other Non-Current Liabilities for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2019 value amounting to $16,000.

  • Black Diamond Therapeutics' Other Non-Current Liabilities fell 99.60% to $16,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $16,000, marking a year-over-year decrease of 99.60%. This contributed to the annual value of $16,000 for FY2019, which is 99.60% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Other Non-Current Liabilities of $16,000 as of FY2019, which was down 99.60% from $4.0 million recorded in FY2018.
  • In the past 5 years, Black Diamond Therapeutics' Other Non-Current Liabilities ranged from a high of $4.0 million in FY2018 and a low of $16,000 during FY2019.
  • Moreover, its 2-year median value for Other Non-Current Liabilities was $2.0 million (2018), whereas its average is $2.0 million.
  • Data for Black Diamond Therapeutics' Other Non-Current Liabilities shows a maximum YoY plummeted of 99.60% (in 2019) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' Other Non-Current Liabilities (Yearly) stood at $4.0 million in 2018, then tumbled by 99.60% to $16,000 in 2019.